Dr. Marlene Llópiz, MD

Medical Director

Dr. Marlene Llópiz possesses extensive knowledge in public health policies and healthcare systems, and has renowned experience in designing, managing and leading large global/multi-national phase I-IV clinical trials for local and international pharmaceutical companies, as well as chief editor of health journals across Latin America.

Marlene is currently living in Mexico and consults in her areas of expertise throughout several countries in the region. Dr. Llópiz works orchestrating efforts in public health between governmental, private and academic organizations including the Ministry of Health of Mexico, the Harvard School of Public Health, the Association of Medical Specialists in the Pharmaceutical Industry and the International Federation of Associations of Pharmaceutical Physicians. She has held country and Latin American responsibilities working at PLM Mexico and for clinical research organizations (CRO) including Quintiles, ICON and other international firms. Marlene has supervised studies in multiple diseases like Alzheimer’s disease, epilepsy, diabetes mellitus, HIV, migraine, dermatology, pediatric asthma; skin, lung, colon, breast, head and neck, and gastric cancer, hypertension, contrast medium, Parkinson’s disease, ulcerative colitis, chronic pain, bipolar disease, osteoporosis, rheumatoid arthritis, schizophrenia, multiple sclerosis and medical devices, as well. She has been Principal Investigator in many bioequivalency trials.

Marlene holds a Master in Public Health (MPH) degree from the Harvard University School of Public Health, a Medical Degree (MD) from the Universidad Anahuac Medical School, a Bachelor of Arts (BA) Degree with majors in Biology and Biochemistry and Pre-Medical Studies, in addition to a certificate in Translation and Interpretation of Spanish and English from Austin College, USA.

Marlene Llópiz received diverse honors and awards for her academic achievements and contributions to the life sciences. Marlene is an active member of International and American Medical Societies and a recognized speaker at clinical meetings across the Americas and Europe. She is author and co-editor of articles and book chapters, and a staff professor at several universities. Marlene is fluent in English, Spanish and French, with a basic knowledge of Japanese and Italian.